Highlights

  • Xero (ASX: XRO)'s role here is purely as a familiar ASX benchmark for a mooted, unconfirmed cyber float; it is not a valuation event for Xero.
  • Xero reported FY26 (year to 31 March 2026) revenue of NZ$2.75 billion, up 31%, with 4.92 million subscribers.
  • Net profit fell about 27% to NZ$167.4 million, weighed down by costs tied to the US$2.5 billion Melio acquisition.
  • The US payments strategy, led by Melio, is now central to the growth story and management's longer-term ambitions.
  • Xero's ASX market capitalisation sat near A$11.6 billion in mid-July 2026, well down from prior highs amid broader concerns about AI and software valuations.

A mooted ASX listing by cybersecurity company Point Wild has prompted commentators to reach for Xero (ASX: XRO) as a size reference. The proposed float is unconfirmed, and the "half the size of Xero" line is an illustration, not a statement about Xero's worth. This article looks at what Xero actually is, its latest FY26 results, the Melio-led US push, and whether using Xero as a yardstick is reasonable.

Every so often, a private company floats the idea of listing in Australia, and the market instinctively reaches for a recognisable name to convey scale. In mid-2026, that name has been Xero (ASX: XRO).

Reports suggest Point Wild, a Boston-based cybersecurity business, is considering an ASX listing that could value it at around $5 billion. To help readers picture that number, some coverage has described it as roughly half the size of Xero.

It is worth stating plainly at the outset: this is a comparison of convenience. Xero is not raising money, not merging, and not the subject of the transaction. The company simply happens to be one of the ASX's better-known technology names.

That makes the interesting question less about Point Wild and more about Xero itself. Is Xero a fair yardstick, and what does its current shape actually look like?

The development

The catalyst is a media-reported, and so far unconfirmed, possibility that Point Wild could pursue an ASX listing. No prospectus, timetable or firm valuation has been confirmed by the company, and the roughly $5 billion figure should be treated as indicative.

Xero enters the story only as a reference point. When a would-be issuer is unfamiliar to local investors, journalists often anchor its scale to a company people already know. Xero, as a large, long-listed software name, fits that role.

Crucially, nothing about the Point Wild speculation changes Xero's fundamentals. It does not add revenue, alter its balance sheet, or validate its share price. The "half the size of Xero" framing is arithmetic, not endorsement.

For Xero shareholders, then, the practical takeaway is straightforward. The headline is not really about their company, even though their company is in the headline.

Company background

Xero was founded in New Zealand in 2006 and built its business on cloud-based accounting software for small and medium enterprises. Rather than desktop software, Xero sells subscriptions to an online platform that connects businesses, their bank feeds and their advisers.

Its core markets have historically been Australia and New Zealand, followed by the United Kingdom, with the United States long treated as a large but underpenetrated opportunity. Accountants and bookkeepers are central to its distribution, often recommending Xero to the businesses they serve.

The company lists on the ASX under the code XRO and reports its financial results in New Zealand dollars, while its market value is quoted in Australian dollars on the exchange. Its chief executive is Sukhinder Singh Cassidy, who has led a sharpened focus on fewer, larger priorities.

A defining recent move was the 2025 acquisition of Melio, a US small-business bill payment provider, for around US$2.5 billion. That deal, completed in October 2025, marked a decisive bet on payments and on the American market.

Latest financial and operational picture

For FY26, the year to 31 March 2026, Xero reported operating revenue of NZ$2.75 billion, up 31% (about 21% on an organic basis). Subscribers reached 4.92 million, an increase of roughly 506,000 over the year.

Average revenue per user (ARPU) rose about 23% to around NZ$55.44, reflecting price increases and the growing contribution of payments and add-ons. Annualised monthly recurring revenue (AMRR) climbed 37% to about NZ$3.27 billion, a forward-looking gauge of subscription momentum.

Profitability was more nuanced. Adjusted EBITDA rose 18% to NZ$757.4 million and free cash flow increased 9% to NZ$554 million, but net profit fell about 27% to NZ$167.4 million, largely due to costs associated with integrating Melio.

Xero also reported a "Rule of 40" outcome of 48.5% for the group. That measure, which sums revenue growth and a profitability margin, is a common software benchmark, with anything above 40 generally viewed favourably.

Why it matters to shareholders

The Point Wild speculation matters to shareholders mainly as a reminder of how the market perceives Xero: as a scale benchmark. Being the reference company can be flattering, but it changes nothing operationally.

What genuinely matters is whether Xero can keep growing subscribers and ARPU while converting that growth into cash. On the FY26 numbers, revenue and recurring measures kept expanding at a healthy clip.

At the same time, the dip in reported net profit shows the cost of ambition. Large acquisitions such as Melio can compress near-term earnings even when the strategic logic is sound.

For long-term holders, the central issue is execution in the United States, not a passing comparison in an unrelated IPO story.

Potential effect on revenue, earnings, margins and cash flow

The Point Wild report has no direct effect on Xero's revenue, earnings, margins or cash flow. Any changes on those fronts will come from Xero's own trading, not from another company's listing plans.

On revenue, the drivers remain subscriber additions, pricing and the ramp-up of payments through Melio in the US. Management has pointed to strong US momentum following the acquisition.

On margins and earnings, the near-term picture reflects acquisition and integration costs. Over time, the question is whether Melio's payments volumes and Xero's pricing power can lift margins back toward the group's longer-term ambitions.

Cash flow remained positive and growing in FY26, which is important for a company investing heavily in product, AI and its US expansion.

Bull case

The optimistic view is that Xero is still early in monetising a vast global base of small businesses. Rising ARPU and AMRR suggest it can extract more value per customer without necessarily needing explosive subscriber growth.

Melio, in this reading, transforms Xero from an accounting tool into a broader financial platform spanning accounting and payments. That could deepen customer engagement and open a much larger US revenue pool.

If the group can sustain a Rule of 40 outcome comfortably above the 40 threshold while lifting free cash flow, it could rebuild investor confidence and, potentially, its valuation multiple over time.

Base case

The measured view accepts that Xero remains a high-quality, growing software business, but one now digesting a very large acquisition. Revenue keeps compounding at a solid rate, while reported profit is temporarily muted by integration costs.

In this scenario, the US opportunity is real but takes time and money to capture, and competition in accounting and payments remains intense. Progress is steady rather than spectacular.

The share price, well below prior peaks in mid-2026, reflects a market weighing that trade-off between durable growth and near-term earnings pressure, alongside broader questions about software valuations.

Bear case

The cautious view focuses on execution risk and valuation. Integrating Melio, competing against entrenched US payment providers and defending pricing all carry the risk of disappointment.

There is also a structural worry hanging over the sector: whether artificial intelligence could erode the value of traditional SaaS tools, or intensify competition in accounting and bookkeeping. That concern has been part of the pressure on Xero's shares.

If growth slows or US returns underwhelm, a still-premium valuation could face further scrutiny, and patience among shareholders could wear thin.

Potential catalysts

  • Further FY27 trading updates showing US subscriber and payments momentum from Melio.
  • Evidence of ARPU expansion as payments and add-ons scale.
  • Progress toward, or commentary on, longer-term Rule of 40 ambitions.
  • New AI-enabled product features that strengthen, rather than threaten, the platform.
  • Clarity on integration costs unwinding and margins normalising.

Material risks

  • Execution risk in integrating Melio and scaling payments in the competitive US market.
  • Margin and earnings pressure from acquisition-related and growth investment costs.
  • The possibility that AI disrupts or commoditises parts of the accounting software market.
  • Foreign-exchange effects, given reporting in New Zealand dollars and multi-currency operations.
  • Valuation risk if growth expectations are not met, following a sizeable share-price decline.

What to watch next

  • Xero's next scheduled results and any interim operational updates for signs of US traction.
  • The trajectory of subscribers, ARPU and AMRR, the platform's key growth gauges.
  • Commentary from management on Melio's contribution and integration progress.
  • Whether the mooted Point Wild listing actually proceeds — and, if so, on what terms.
  • Broader sentiment toward software and AI-exposed names on the ASX.

Conclusion

The Point Wild story is a useful case study in how markets communicate scale. When an unfamiliar company floats a listing, a recognisable name like Xero (ASX: XRO) becomes convenient shorthand.

But shorthand is all it is. The mooted float is unconfirmed, and describing it as half the size of Xero tells you about Point Wild's rumoured ambitions, not about Xero's worth or outlook.

On its own merits, Xero remains a large, growing accounting platform now reshaping itself around US payments through Melio, with strong revenue and cash flow but softer reported profit as it invests. Whether the comparison is "fair" is almost beside the point; the more important story is Xero's own execution in the years ahead. Nothing here is a recommendation to buy, sell or hold.